Marijuana Reclassified: A Paradigm Shift in U.S. Drug Policy

The U.S. Department of Justice has announced a significant policy shift, reclassifying FDA-approved and state-licensed marijuana as a less dangerous drug. This decision moves marijuana from Schedule I to Schedule III, potentially removing barriers to research and marking a historic change in federal marijuana policy.


Devdiscourse News Desk | Updated: 23-04-2026 18:14 IST | Created: 23-04-2026 18:14 IST
Marijuana Reclassified: A Paradigm Shift in U.S. Drug Policy
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The U.S. Department of Justice has announced a historic shift in drug policy by reclassifying FDA-approved and state-licensed marijuana as a less dangerous substance.

U.S. Acting Attorney General Todd Blanche confirmed the decision, which moves marijuana from Schedule I to Schedule III, highlighting a significant alteration in federal stance.

This reclassification could pave the way for expanded research into marijuana's medical and therapeutic use cases, marking one of the most substantial policy changes in decades.

(With inputs from agencies.)

Give Feedback